SnagRx vs Pallas Health: Pricing, meds, and clinician choice
The core comparison between SnagRx vs Pallas Health comes down to pricing structure, medication options, clinician selection, and how compounded drugs are handled. Early verdict: choose SnagRx if you want a lowest-in-market annual compounded price with a price lock; choose Pallas Health if you want a clinician to select between FDA-approved brand pens and compounded preparations.
See SnagRx annual plan pricing
Quick contrast: pricing model and medication choices
Both providers offer clinician-reviewed, direct-pay telehealth for GLP-1s and both use US compounding pharmacies when a compounded route is provided. Key differences supported by the sources are: SnagRx advertises a 12-month plan with semaglutide from $69/month and tirzepatide from $119/month and a locked flat rate at every dose; Pallas Health offers FDA-approved brand-name Wegovy, Ozempic, Zepbound and Mounjaro in addition to compounded semaglutide, with compounded semaglutide at $139 first month then $597 every 12 weeks (about $199/month average).
Distinctive difference 1: Price point and commitment
SnagRx: the $69 semaglutide and $119 tirzepatide figures are the 12-month plan rates; month-to-month equivalents are $99 and $149. The sources state that the annual plan locks pricing flat at every dose for the life of treatment.
Pallas Health: compounded semaglutide starts at $139 for the first month, then renews every 12 weeks at $597 (a $199/mo average). Pallas prices compounded plans by medication rather than by milligram so the plan price does not rise as titration occurs. Pallas also lists cash-pay brand prices separately.
View Pallas Health plan options
Distinctive difference 2: Brand-name availability vs compounded-only emphasis
Pallas Health explicitly offers both FDA-approved brand pens and compounded semaglutide or tirzepatide, with a clinician personalizing the choice. SnagRx provides compounded semaglutide and tirzepatide only and does not offer branded Ozempic, Wegovy, Mounjaro or Zepbound according to the source.
Distinctive difference 3: Clinician network, named pharmacies, and care features
SnagRx names its four US 503A partner pharmacies and states care is delivered through OpenLoop Health clinicians; the site notes clinician review typically within five hours and next-day shipping. SnagRx also cites LegitScript certification and an outcome guarantee subject to terms.
Pallas Health publishes a medical team and offers one all-in plan price that includes provider care, ongoing check-ins and messaging with no separate membership fee. Pallas is 100% online and asynchronous in most states and states eligibility is determined by a US-licensed clinician.
Check SnagRx clinician and pharmacy details
Shipping, renewals, and regimen cadence
SnagRx promises next-day UPS/FedEx shipping in temperature-controlled packaging for approved orders and refunds if a prescription is declined. Pallas offers free expedited and discreet shipping and renews compounded plans every 12 weeks, which changes the timing for cancellations and renewals.
Regulatory and product notes
Both sources include the regulatory caveat that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. SnagRx and Pallas each state compounded medications are prepared by US compounding pharmacies and that appearance may vary from site imagery.
| Criteria | SnagRx | Pallas Health |
|---|---|---|
| Starting compounded semaglutide | $69/mo on 12-month plan | $139 first month · then $199/mo avg |
| Pricing behavior during titration | Price locked flat at every dose for life | Priced by medication so plan price does not rise with titration |
| Brand-name GLP-1s | No branded pens; compounded only | Offers Wegovy, Ozempic, Zepbound, Mounjaro or compounded |
| Clinician network / support | OpenLoop Health clinicians; review typically within 5 hours | US-licensed clinicians; care and check-ins included |
| Shipping & pharmacies | Names four US 503A partner pharmacies; next-day shipping | Compounded in the USA; free expedited shipping |
What the sources do not supply
The provided evidence does not supply comparative efficacy, specific refill portal features beyond what is stated, state-by-state eligibility details beyond the clinician coverage notes, or patient outcomes beyond self-reported program data. Do not infer outcomes or insurance coverage from the sources.
Explore Pallas clinician-led choices
Start SnagRx intake and pricing details
Conclusion: SnagRx vs Pallas Health
SnagRx and Pallas Health serve different priorities. SnagRx targets price-sensitive users willing to commit to a 12-month plan to lock a low compounded rate and names partner pharmacies and OpenLoop clinicians. Pallas Health focuses on clinician choice between brand-name pens and compounded medication, bundles provider care and messaging into an all-in plan, and prices compounded plans by medication with a first-month intro price.
Choose SnagRx if you want the lowest annual compounded price with a flat price lock and named pharmacy and clinician partners. Choose Pallas Health if you want a clinician to select between FDA-approved brand pens or a compounded preparation and prefer an all-in plan that includes check-ins and messaging.